Cava Healthcare USPTO patents

Utility

Modulation of Cancer Immunity with Type 2 Innate Lymphoid Cells, Interleukin 33, And/or Interferon Induced Protein 44

21 Jul 22

The present invention provides methods of modulating of cancer immunity using type 2 innate lymphoid cells (ILC2s), interleukin 33 (IL-33), IFI44 or combination thereof.

Wilfred Jefferies, Iryna Yuriyivna Saranchova

Filed: 19 Nov 21

Utility

Curcuphenol Compounds for Increasing Mhc-i Expression

3 Mar 22

Provided are methods of using curcuphenol compounds to increase expression of major histocompatibility complex class I (MHC-I) antigen in cells, particularly on the surface of diseased cells such as cancer cells, and thereby increase the immunogenicity of the cells.

Wilfred Jefferies, Reinhard Gabathuler, Raymond Andersen, Lilian Nohara, David Williams

Filed: 8 Nov 21

Utility

qy1bc221dmnkmr23we4hrwnr8ew2qqcmtyyypa0m8yps7nyyy zezait9rm

4 Jan 22

The present invention provides methods of modulating of cancer immunity using type 2 innate lymphoid cells (IL-C2s), interleukin 33 (IL-33), IFI44 or combination thereof.

Wilfred Jefferies, Iryna Yuriyivna Saranchova

Filed: 3 Mar 16

Utility

3b47x80szp3tyehficlmezqh61qdcyv7lz3ald2iazid1iewo7ai

14 Dec 21

Provided are methods of using curcuphenol compounds to increase expression of major histocompatibility complex class I (MHC-I) antigen in cells, particularly on the surface of diseased cells such as cancer cells, and thereby increase the immunogenicity of the cells.

Wilfred Jefferies, Reinhard Gabathuler, Raymond Andersen, Lilian Nohara, David Williams

Filed: 20 Aug 20

Utility

uu7optybw1dvhqk0kh4m999xtjbqna

8 Apr 21

Methods for diagnosing and treating Alzheimer's disease are provided.

Wilfred Jefferies, Kaan E. Biron, Dara L. Dickstein

Filed: 18 Sep 20

Utility

t8ovtghvhq irqz9rg336q4mblmkf8x5i

2 Dec 20

Provided are methods of using curcuphenol compounds to increase expression of major histocompatibility complex class I (MHC-I) antigen in cells, particularly on the surface of diseased cells such as cancer cells, and thereby increase the immunogenicity of the cells.

Wilfred Jefferies, Reinhard Gabathuler, Raymond Andersen, Lilian Nohara, David Williams

Filed: 19 Aug 20

Utility

qyh7nb30xzs01217ku87ii1vxv046m595io6uz 73zcyplvr53s

24 Aug 20

Provided are methods of using curcuphenol compounds to increase expression of major histocompatibility complex class I (MHC-I) antigen in cells, particularly on the surface of diseased cells such as cancer cells, and thereby increase the immunogenicity of the cells.

Wilfred Jefferies, Reinhard Gabathuler, Raymond Andersen, Lilian Nohara, David Williams

Filed: 24 Jan 17